TY - JOUR
T1 - Patient-Reported Outcomes in First-Line Antiretroviral Therapy: Results From NEAT001/ANRS143 Trial Comparing Darunavir/Ritonavir in Combination With Tenofovir/Emtricitabine or Raltegravir
AU - NEAT 001/ANRS 143 Study Group
AU - George, Elizabeth C.
AU - Bucciardini, Raffaella
AU - Richert, Laura
AU - Dedes, Nikos
AU - Fragola, Vincenzo
AU - Nieuwkerk, Pythia
AU - Spire, Bruno
AU - Volny-Anne, Alain
AU - West, Brian
AU - Molina, Jean-Michel
AU - Horban, Andrzej
AU - Fox, Julie
AU - Pozniak, Anton
AU - Vella, Stefano
AU - Termote, Monique
AU - Raffi, François
PY - 2018
Y1 - 2018
N2 - BACKGROUND: There are few data comparing patient-reported outcomes (PROs) in randomized trials of initial antiretroviral therapy. We present results from a substudy of the NEAT001/ANRS143 trial.
AB - BACKGROUND: There are few data comparing patient-reported outcomes (PROs) in randomized trials of initial antiretroviral therapy. We present results from a substudy of the NEAT001/ANRS143 trial.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85055613344&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/30234665
U2 - https://doi.org/10.1097/QAI.0000000000001844
DO - https://doi.org/10.1097/QAI.0000000000001844
M3 - Article
C2 - 30234665
SN - 1525-4135
VL - 79
SP - 519
EP - 526
JO - Journal of acquired immune deficiency syndromes (1999)
JF - Journal of acquired immune deficiency syndromes (1999)
IS - 4
ER -